Skip to main content
OpenTrials

Clinical trial condition

Nervous System Neoplasms

Explore clinical trials studying Nervous System Neoplasms. Study availability and eligibility vary by location and protocol.

2,886 public trials 685 recruiting studies
Refine in advanced search Browse all conditions

Nervous System Neoplasms trial results

Active, Not Recruiting

Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations

NCT04521686

Conditions
Adenocarcinoma, Any Solid Tumor, Astrocytoma, +49 more
Locations
  • Mayo Clinic of Scottsdale Phoenix, Arizona, United States
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • USC Norris Cancer Hospital Los Angeles, California, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
View all 33 locations
View Trial Details
Active, Not Recruiting

Osimertinib With or Without Bevacizumab in Treating Patients With EGFR Positive Non-small Cell Lung Cancer and Brain Metastases

NCT02971501

Conditions
Brain Diseases, Brain Neoplasms, Bronchial Neoplasms, +16 more
Locations
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Keck Medical Center of USC Pasadena Pasadena, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
View all 18 locations
View Trial Details
Active, Not Recruiting

Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors

NCT02867592

Conditions
Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +92 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Kaiser Permanente-Anaheim Anaheim, California, United States
View all 142 locations
View Trial Details
Active, Not Recruiting

Intrathecal Dual Checkpoint Inhibitor (PD-1 and CTLA-4) in Combination With Pemetrexed for Leptomeningeal Metastasis

NCT06809530

Conditions
CTLA4, Central Nervous System Neoplasms, Leptomeningeal Metastasis, +9 more
Locations
  • Aerospace Center Hospital, Peking University Aerospace School of Clinical Medicine Beijing, Beijing Municipality, China
  • The Affiliated Huizhou Hospital, Guangzhou Medical University Huizhou, Guangdong, China
  • Huizhou First Hospital Affiliated to Guangdong Medical University Huizhou, Guangdong, China
  • Beijing Chest Hospital, Capital Medical University Beijing, China
View Trial Details
Active, Not Recruiting

Intrathecal Combination of Programmed Death-1 (PD-1)/Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) Bispecific Antibody and Pemetrexed for Leptomeningeal Metastasis

NCT06762080

Conditions
Central Nervous System Neoplasms, Leptomeningeal Metastasis, Meningeal Carcinomatosis, +5 more
Locations
  • The Affiliated Huizhou Hospital, Guangzhou Medical University Huizhou, Guangdong, China
  • Beijing Chest Hospital, Capital Medical University Beijing, China
View Trial Details
Active, Not Recruiting

Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis

NCT04225871

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Mg0011 41 Mobile, Alabama, United States
  • Mg0011 116 Phoenix, Arizona, United States
  • Mg0011 31 Irvine, California, United States
  • MG0011 4 Los Angeles, California, United States
View all 70 locations
View Trial Details
Active, Not Recruiting

Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma

NCT02359565

Conditions
Brain Diseases, Brain Neoplasms, Brain Stem Neoplasms, +46 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
View Trial Details

Related conditions